- Two-year effectiveness of zoledronic acid with or without eldecalcitol in Japanese patients with osteoporosis: A randomized prospective study
-
Mochizuki T, Yano K, Ikari K, Okazaki K
- KMID: 2537733
- Osteoporos Sarcopenia.
- 2022 Jun;8(2):75-79.
- doi: 10.1016/j.afos.2022.05.001
Objectives: This study aims to examine the 2-year outcomes of zoledronic acid (ZOL) with or without eldecalcitol (ELD) on bone mineral density (BMD) and fracture in Japanese patients with osteoporosis. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study
-
Mochizuki T, Yano K, Ikari K, Okazaki K
- KMID: 2520672
- Osteoporos Sarcopenia.
- 2021 Sep;7(3):110-114.
- doi: 10.1016/j.afos.2021.08.001
Objectives To investigate effects of romosozumab treatment on disease activity and bone mineral density (BMD) in patients with rheumatoid arthritis (RA) and severe osteoporosis in comparison with effects of denosumab treatment. Methods A... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study
-
Nakayama M, Furuya T, Inoue E, Tanaka E, Ikari K, Taniguchi A, Yamanaka H, Harigai M
- KMID: 2503948
- Osteoporos Sarcopenia.
- 2020 Jun;6(2):82-87.
- doi: 10.1016/j.afos.2020.04.003
Objectives: This study aimed to evaluate factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis (RA). Methods: Patients with RA who enrolled in our cohort completed self-administered questionnaires... -
- CITED
-
- Close
- SHARE
-
- Close
